USP Compounding Updates Nearing Publication, Implementation

USP Compounding General Chapters are nearing publication (June 1, 2019) and implementation (December 1, 2019): <795> Pharmaceutical Compounding – Nonsterile Preparations (revised chapter published June 2019) <797> Pharmaceutical Compounding – Sterile Preparations (revised chapter published June 2019) <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging (new chapter published June 2019) You can stay up-to-date on […]

Three Reasons Why USP Supports Pharmacist Provider Status Legislation

The chief executive officer of USP, Ronald T. Piervincenzi, Ph.D., just posted the three reasons why USP is supporting pharmacist healthcare provider status legislation. The Pharmacy and Medically Underserved Areas Enhancement Act, which was recently reintroduced in both houses of Congress (H.R. 592, S. 109), would include pharmacists on the list of recognized healthcare providers […]

Final USP Letter on Biologics Released

The final letter to the Senate Committee on Health, Education, Labor and Pensions regarding the inclusion of Section 11, Biologic Product Innovation in the FDA and NIH Workforce Authorities Modernization Act (S. 2700) has been released.  The proposed language in S. 2700 would carve biologic products out of the requirement to adhere to public quality standards—basically bypassing the […]

NASPA Signs on to USP Letter on Biologics Provision

NASPA, along with USP, AMCP, APhA, ASHP, The Biosimilars Council, NCPA, NCPDP, and PCMA, has signed on to a letter to the Senate Committee on Health, Education, Labor and Pensions regarding the inclusion of Section 11, Biologic Product Innovation in the FDA and NIH Workforce Authorities Modernization Act (S. 2700).  The proposed language in S. 2700 would […]